Vancomycin Hydrochloride Pricing Report ​2024​: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Vancomycin Hydrochloride Pricing Report ​2024​: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Report Format: PDF+Excel | Report ID: SR112024A23183
Buy Now

Vancomycin Hydrochloride Prices June 2023

Product
Category Region Price
Vancomycin Hydrochloride Pharma API USA 633130 USD/MT
Vancomycin Hydrochloride Pharma API China 630422 USD/MT
Vancomycin Hydrochloride Pharma API Germany 670750 USD/MT


The price of vancomycin hydrochloride in the United States for Q4 2023 reached 633130 USD/MT in June 2023. In the US, Vancomycin prices dropped by 6.68% in May compared to April due to increased supply, reduced demand, and currency weakening. This decline reversed in June with a 1.98% price increase, driven by rising end-consumer demand and a lower PMI.

The price trend for vancomycin hydrochloride in China reached 630422 USD/MT in June 2023. Vancomycin prices in the Asia Pacific fell by 6.80% in May from the previous month due to higher supply, lower demand, and currency fluctuations. However, June saw a 1.93% price increase due to rising demand and improved trade activity.

In Germany, vancomycin hydrochloride prices Germany experienced a 6.72% drop in Vancomycin prices in May, reaching 670750 USD/MT. This can be attributed to the weak purchasing momentum and ample stocks. In June, prices rose by 1.92% as demand from end-user sectors increased despite economic challenges.

Vancomycin Hydrochloride Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Vancomycin Hydrochloride Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of vancomycin hydrochloride pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot prices at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of price trends across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing vancomycin hydrochloride price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Vancomycin Hydrochloride Price Trend

Vancomycin Hydrochloride Market Analysis

The global vancomycin hydrochloride market size reached US$ 740 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 1035.2 Million, at a projected CAGR of 3.80% during 2023-2032.

  • The global rise in multidrug-resistant bacterial infections, particularly MRSA (methicillin-resistant Staphylococcus aureus), has led to an elevated demand for vancomycin hydrochloride.
  • Recent technological advancements in pharmaceutical manufacturing have enhanced the production efficiency and quality of vancomycin hydrochloride.
  • Governments worldwide are implementing stricter antibiotic stewardship programs to combat antibiotic resistance. Such policies support sustained demand and research into its clinical applications.
  • As healthcare infrastructure expands in developing regions, access to critical medications such as vancomycin hydrochloride increases.
  • The aging global population is more susceptible to infections due to weaker immune systems, thereby necessitating robust treatment options.
  • There is a heightened focus on preventing and treating hospital-acquired infections, which commonly involve resistant bacteria. Vancomycin HCL remains a first-line treatment for these infections due to its effectiveness against resistant strains.
  • Globally, there is an increase in healthcare spending, which includes significant investments in effective antimicrobial agents. This financial support ensures its availability and continuous use in medical facilities.
  • Outbreaks of infectious diseases often require rapid and effective treatment protocols in which vancomycin hydrochloride plays a critical role. The ongoing readiness to manage epidemics influences stockpiling practices and steady market demand.
  • Strategic collaborations and partnerships among pharmaceutical companies facilitate the development and distribution of essential drugs, including vancomycin hydrochloride. These alliances help streamline production processes and expand market reach. As a result, such collaborations ensure that effective treatments remain available to combat serious bacterial infections globally.

Vancomycin Hydrochloride News

The report covers the latest developments, updates, and trends impacting the global vancomycin hydrochloride market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in vancomycin hydrochloride production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that shape the industry landscape.

Latest developments in the vancomycin hydrochloride industry:

  • March 27, 2024: Amneal Pharmaceuticals, LLC. Bridgewater, New Jersey (Amneal), is voluntarily recalling 4 lots of Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL packaged in 80 mL, 150 mL, or 300 mL pack sizes, to the Consumer Level. Some bottles may have been overfilled which can result in an over potent dosing regimen.
  • December 27, 2023: Eli Lilly has completed the acquisition of POINT Biopharma, expanding its capabilities in radiopharmaceutical therapies, which could complement their antibiotic portfolio including vancomycin.

Product Description

Vancomycin hydrochloride, a glycopeptide class antibiotic, is utilized to treat serious bacterial infections, particularly those caused by Gram-positive bacteria resistant to other antibiotics. Its somewhat complicated configuration enables it to hinder the formation of bacterial cell walls, thus preventing the proliferation and replication of bacteria. Vancomycin is produced through a fermentation method involving a specific bacterium called Amycolatopsis orientalis. Following the fermentation process, the compound is extracted and subsequently purified.

Additional chemical processes ensure its transformation into a hydrochloride salt form, which enhances some of its properties, including its solubility, and hence its stability, and is why it is used in a medical context both in injectable and oral forms. It is highly efficient in treating certain infections, like those resulting from methicillin-resistant Staphylococcus aureus, and is viewed as a final option medication for specific bacterial pneumonia, septicemia, and endocarditis cases.

Regional Coverage

The report provides a detailed analysis of the vancomycin hydrochloride market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the price trends. 

Global Vancomycin Hydrochloride Price

The report offers a holistic view of the global vancomycin hydrochloride pricing trends, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level.

Europe Vancomycin Hydrochloride Price

In Germany, Vancomycin prices fell by 6.72% in May from April due to weak purchasing momentum and excess stock. Increased manufacturing output and eased import protocols boosted supply and availability of generic Vancomycin. The PMI dropped to 42.9 in May, reflecting a slowing economy impacted by the Ukraine war and 7.9% inflation, reducing Vancomycin demand. In June, prices rose by 1.92% due to higher demand from end-user sectors.

This analysis can be extended to include detailed vancomycin hydrochloride price information for a comprehensive list of countries.

Region Countries Covered
Europe Germany, France, United Kingdom, Italy,  Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.


North America Vancomycin Hydrochloride Price

In the US, Vancomycin prices decreased by 6.68% in May compared to April due to increased supply, reduced demand, and currency weakening. China and India, major producers, boosted production to meet higher demand, and eased export regulations increased global availability. The war in Ukraine and inflation reduced Vancomycin demand. In June, prices rose by 1.98% due to growing consumer demand and a lower Price Manager Index (PMI).

Specific data on vancomycin hydrochloride prices within the United States and Canada can also be provided.

Region Countries Covered
North America United States and Canada


Middle East and Africa Vancomycin Hydrochloride Price

The report explores the vancomycin hydrochloride pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on vancomycin hydrochloride prices for countries can also be provided.

Region Countries Covered
Middle East & Africa Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.


Asia Pacific Vancomycin Hydrochloride Price

Vancomycin prices in the Asia Pacific region dropped by 6.80% in May from April due to increased supply, lower demand, and currency fluctuations. Lower raw material costs for Vancomycin API production and a stronger Chinese Yuan against the US dollar contributed to the price decline. China's PMI rose to 50.9 in May, indicating industrial expansion and limited demand. In June, prices increased by 1.93% due to higher consumer demand and improved trade activity.

This analysis can be further extended to include detailed vancomycin hydrochloride prices for a comprehensive list of countries within the region.

Region Countries Covered
Asia Pacific China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.


Latin America Vancomycin Hydrochloride Price

The analysis of vancomycin hydrochloride prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Region Countries Covered
Latin America Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.


Report Coverage

Key Attributes Details
Product Name Vancomycin Hydrochloride
Report Features Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Price Analysis, and Segment-Wise Assessment.
Currency/Units US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered The current coverage includes analysis at the global and regional levels only. 
 
Based on your requirements, we can also customize the report and provide specific information for the following countries: 
 
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
 
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* 
 
North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*

Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*

*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers
  • Company Overview
  • Business Description
  • Product Portfolio
  • Recent Trends and Developments
Customization Scope The report can be customized as per the requirements of the customer
Report Price and Purchase Option

Plan A: Monthly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Month
    • Forecast for Next Month
  • Total Deliverables Per Year: 12 (One Per Month)
  • Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year

Plan B: Quarterly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Quarter
    • Forecast for Next Quarter
  • Total Deliverables Per Year: 4 (One Per Quarter)
  • Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year

Plan C: Biannually Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Half
    • Forecast for the Next Half
  • Total Deliverables Per Year: 2 (One Per 6 Months)
  • Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year  
Post-Sale Analyst Support  360-degree analyst support after report delivery
Delivery Format PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) 

Key Benefits for Stakeholders:

  • IMARC’s report presents a detailed analysis of vancomycin hydrochloride pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
  • The study examines factors affecting vancomycin hydrochloride price volatility, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
  • The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
  • IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the vancomycin hydrochloride industry.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Vancomycin Hydrochloride Pricing Report ​2024​: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data
Purchase options
For 2 Deliverables, Billed Annually

For 4 Deliverables, Billed Annually

For 12 Deliverables, Billed Annually


Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More